New MS Drug Yields Mixed Results in Study

WEDNESDAY, Oct. 7, 2015 — Multiple sclerosis patients taking a new drug experienced fewer relapse rates but more side effects than patients receiving a standard MS therapy, new research indicates.
In a trial comparing two sets of more than 900…
Source: Topamax